Related Experiment Video
Updated: Jul 23, 2025

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
Published on: June 16, 2020
Targeting cAMP signaling compartments in iPSC-derived models of cardiovascular disease
1Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Germany; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.
Abstract:
Adenosine 3',5'-cyclic monophosphate (cAMP) acts as a second messenger that is involved in the regulation of a plethora of processes. The activation of cAMP signaling in defined compartments is critical for cells to respond to an extracellular stimulus in a specific manner. Rapid advances in the field of human induced pluripotent stem cells (iPSCs) reflect their great potential for cardiovascular disease modeling, drug screening, regenerative and precision medicine. This review discusses cAMP signaling in iPSC-derived cardiovascular disease models, and the prospects of using such systems to elucidate disease mechanisms, drug actions and to identify novel drug targets for the treatment of cardiovascular diseases with unmet medical need, such as hypertension and heart failure.
Insights
Adenosine 3
Area of Science:
- Cardiovascular Science
- Cell Signaling
- Stem Cell Biology
Background:
- Adenosine 3',5'-cyclic monophosphate (cAMP) is a crucial second messenger regulating cellular processes.
- Compartmentalized cAMP signaling is essential for specific cellular responses to stimuli.
- Human induced pluripotent stem cells (iPSCs) offer significant potential in cardiovascular research.
Purpose of the Study:
- To review the role of cAMP signaling in iPSC-derived cardiovascular disease models.
- To explore the utility of these models for understanding disease mechanisms and drug actions.
- To identify new therapeutic targets for cardiovascular diseases like hypertension and heart failure.
Main Methods:
- Literature review of studies on cAMP signaling in iPSC-derived cardiovascular models.
- Analysis of current applications and future prospects of iPSC technology in cardiovascular research.
- Discussion of therapeutic strategies for cardiovascular diseases.
Main Results:
- iPSC-derived cardiovascular models provide a platform to study cAMP signaling in disease contexts.
- These models facilitate drug screening and the identification of novel therapeutic targets.
- Understanding cAMP signaling in iPSCs can advance precision medicine for cardiovascular conditions.
Conclusions:
- iPSC-derived cardiovascular models are valuable tools for studying cAMP signaling in cardiovascular diseases.
- Targeting cAMP pathways in iPSC models holds promise for developing treatments for hypertension and heart failure.
- This approach supports the advancement of regenerative and precision medicine in cardiology.
More Related Videos
05:06Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
09:23Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
Published on: March 10, 2023